| 1 |
27980102 | Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. | 2017 Feb |
1 |
| 2 |
28108630 | Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer. | 2017 Mar |
1 |
| 3 |
27611715 | In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis. | 2016 Oct |
4 |
| 4 |
25854569 | [Sodium butyrate down-regulates IFN-γ-induced indoleamine 2, 3 dioxygenase and promotes its acetylation and ubiquitination in CNE2 nasopharyngeal carcinoma cells]. | 2015 Apr |
7 |
| 5 |
23942267 | Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells. | 2013 Oct 10 |
5 |
| 6 |
22124136 | Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. | 2012 Feb |
1 |
| 7 |
20691806 | Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels. | 2010 Nov |
1 |
| 8 |
17540780 | Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-gamma/TNF-alpha. | 2007 Jul |
3 |
| 9 |
15318170 | Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. | 2004 Aug 19 |
1 |